BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20006304)

  • 1. Anti-tuberculosis immunity induced in mice by vaccination with Mycobacterium smegmatis over-expressing Antigen 85B is due to the increased influx of IFNgamma-positive CD4 T cells into the lungs.
    Lindsey DR; Dhandayuthapani S; Jagannath C
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1(Suppl 1):S46-8. PubMed ID: 20006304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM; Smith A; Lindsey DR; Meher A; Schluns K; Arora A; Armitige LY; Jagannath C
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
    Gillis TP; Tullius MV; Horwitz MA
    Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.
    Moguche AO; Musvosvi M; Penn-Nicholson A; Plumlee CR; Mearns H; Geldenhuys H; Smit E; Abrahams D; Rozot V; Dintwe O; Hoff ST; Kromann I; Ruhwald M; Bang P; Larson RP; Shafiani S; Ma S; Sherman DR; Sette A; Lindestam Arlehamn CS; McKinney DM; Maecker H; Hanekom WA; Hatherill M; Andersen P; Scriba TJ; Urdahl KB
    Cell Host Microbe; 2017 Jun; 21(6):695-706.e5. PubMed ID: 28618268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial reconstitution of the CD4+-T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines.
    D'Souza S; Romano M; Korf J; Wang XM; Adnet PY; Huygen K
    Infect Immun; 2006 May; 74(5):2751-9. PubMed ID: 16622212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice.
    Wang P; Wang L; Zhang W; Bai Y; Kang J; Hao Y; Luo T; Shi C; Xu Z
    Hum Vaccin Immunother; 2014; 10(1):150-8. PubMed ID: 23982126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
    Villarreal DO; Siefert RJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
    Derrick SC; Yang AL; Morris SL
    Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.
    Dalmia N; Klimstra WB; Mason C; Ramsay AJ
    PLoS One; 2015; 10(8):e0136635. PubMed ID: 26317509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis antigen 85B modifies BCG-induced antituberculosis immunity and favors pathogen survival.
    Piccaro G; Aquino G; Gigantino V; Tirelli V; Sanchez M; Iorio E; Matarese G; Cassone A; Palma C
    J Leukoc Biol; 2024 May; 115(6):1053-1069. PubMed ID: 38242866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.
    Chang-hong S; Xiao-wu W; Hai Z; Ting-fen Z; Li-Mei W; Zhi-kai X
    DNA Cell Biol; 2008 Apr; 27(4):199-207. PubMed ID: 18163878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
    Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
    Meerak J; Wanichwecharungruang SP; Palaga T
    Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.